IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$37.59
+0.37% today
Updated 2026-09-11
Market cap
$3.70B
P/E ratio
—
P/S ratio
15.80x
EPS (TTM)
$-1.92
Dividend yield
—
52W range
$24 – $43
Volume
0.8M
Ideaya Biosciences Inc (IDYA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$37.59
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$139.73
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.0B | $0.0B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -74.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.